ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

VIGL Vigil Neuroscience Inc

2.71
0.13 (5.04%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 46,561
Bid Price 2.61
Ask Price 2.83
News -
Day High 2.74

Low
2.50

52 Week Range

High
11.11

Day Low 2.50
Company Name Stock Ticker Symbol Market Type
Vigil Neuroscience Inc VIGL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.13 5.04% 2.71 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.62 2.50 2.74 2.71 2.58
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
728 46,561 $ 2.59 $ 120,619 - 2.50 - 11.11
Last Trade Time Type Quantity Stock Price Currency
18:56:37 1 $ 2.83 USD

Vigil Neuroscience Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
98.3M 35.88M - 0 -82.64M -2.30 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vigil Neuroscience News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VIGL Message Board. Create One! See More Posts on VIGL Message Board See More Message Board Posts

Historical VIGL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.702.962.502.7260,3390.010.37%
1 Month3.453.522.503.0755,905-0.74-21.45%
3 Months2.693.622.503.1089,5850.020.74%
6 Months8.369.242.503.50111,623-5.65-67.58%
1 Year8.5911.112.505.1886,362-5.88-68.45%
3 Years12.0018.272.187.3669,015-9.29-77.42%
5 Years12.0018.272.187.3669,015-9.29-77.42%

Vigil Neuroscience Description

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families.

Your Recent History

Delayed Upgrade Clock